Patti E. Gravitt (United States of America)
University of Maryland School of Medicine Epidemiology and Public Health
Presenter of 2 Presentations
RATES OF NEW HPV DETECTION AND LOSS OF DETECTION AMONG MIDDLE-AGED WOMEN IN THE US: ATTRIBUTION TO RECENT ACQUISITION VS NEW DETECTION (ID 955)
Session Time
10:00 - 17:00
Session Type
Poster Viewing - 20-24 July
Session Name
Public Health / Epidemiology / Epidemiology: Natural History/Risk Factors
Lecture Time
10:15 - 10:16
Introduction
The United States Advisory Committee on Immunization Practices (ACIP) does not recommend routine HPV vaccination for persons over age 26 years but allows vaccination up to age 45 if a benefit to the patient is perceived. Assuming that benefit is gained predominately through prevention of acquisition of new infection (versus reactivation of latent infection), we estimated the fraction of new HPV detections due to new acquisition vs. redetection/reactivation among 731 women aged 35-60 years in Baltimore, MD.
Methods
During 2008-2011, a cervical brush sample was collected for HPV testing by a trained study physician or nurse and participants completed health and sexual behavior questionnaires at baseline and every 6-months over a 2-year period. Rates of new HPV detection were calculated using Kaplan-Meier methods, stratified by recent and past sexual behavior. Population attributable fractions (PAFs) of new HPV detection due to new acquisition vs. redetection were estimated.
Results
Rates of new detection were highest in women reporting a new partner regardless of sexual history, however rates of new detection were over 2-fold higher in women with 5+ lifetime sex partners (LTSP) compared to women with <5 LTSP (Table 1, Figure 1). Of the 67 new HPV detections, 18% occurred in women with <5 LTSP and no new partner, 63% in women with ≥5 LTSP and no new partner, and 19% in women with a new partner. The PAF of new HPV detection due to new acquisition was 17.0% versus 34.3% due to having 5+ LTSP.
Conclusions
Recent and past sexual behavior independently affects the risk of having a new HPV type detected in this mid-adult population, suggesting that new detection reflects both recent acquisition and recurrent detection of previously acquired infection. These results may be useful in counseling older women undergoing routine HPV-based cervical screening and considering HPV vaccination.
Hide
DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS: A PILOT STUDY IN PERU (ID 434)
Session Time
08:45 - 09:45
Session Type
Public Health Oral Session
Lecture Time
09:33 - 09:45
[{"name":"DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS: A PILOT STUDY IN PERU \u003Csmall\u003E(ID 434)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":434,"presentation":"DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS: A PILOT STUDY IN PERU \u003Csmall\u003E(ID 434)\u003C\/small\u003E","session":"Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening","presenter":"Patti E. Gravitt (United States of America)","photo":""},"playlist":[{"name":"DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/Patti Gravitt - IPVC20 -PRESENTATION id 434 DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS A PILOT STUDY IN PERU.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/31\/Patti Gravitt - IPVC20 -PRESENTATION id 434 DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS A PILOT STUDY IN PERU.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/A4AE283B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/Patti Gravitt - IPVC20 -PRESENTATION id 434 DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS A PILOT STUDY IN PERU.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"6E22UU08u"}
[session]
[presentation]
[presenter]
Hide
Moderator of 1 Session
Session Type
Public Health Oral Session
Session Time
12:35 - 13:50
[{"name":"DETECTION OF SOMATIC HOTSPOT MUTATIONS IN CERVICAL PRECANCEROUS LESIONS USING CERVICAL CELLS. \u003Csmall\u003E(ID 1046)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1046,"presentation":"DETECTION OF SOMATIC HOTSPOT MUTATIONS IN CERVICAL PRECANCEROUS LESIONS USING CERVICAL CELLS. \u003Csmall\u003E(ID 1046)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Maisa Pinheiro (United States of America)","photo":""},"playlist":[{"name":"9c770ce5c4dd9cb4dee0497d8a37a98a","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/9c770ce5c4dd9cb4dee0497d8a37a98a.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/9c770ce5c4dd9cb4dee0497d8a37a98a.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/BCFC07F6.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/9c770ce5c4dd9cb4dee0497d8a37a98a.vtt"}]},{"name":"WHO INTERNATIONAL STANDARDS FOR HPV DNA FOR LOW-RISK TYPES HPV6 & HPV11 AND HIGH-RISK TYPES HPV31, HPV33, HPV45, HPV52 & HPV58 \u003Csmall\u003E(ID 553)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":553,"presentation":"WHO INTERNATIONAL STANDARDS FOR HPV DNA FOR LOW-RISK TYPES HPV6 & HPV11 AND HIGH-RISK TYPES HPV31, HPV33, HPV45, HPV52 & HPV58 \u003Csmall\u003E(ID 553)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Dianna E. Wilkinson (United Kingdom)","photo":""},"playlist":[{"name":"WHO INTERNATIONAL STANDARDS FOR HPV DNA FOR LOW-RISK TYPES HPV6 & HPV11 AND HIGH-RISK TYPES HPV31, H","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/GMT20200611-124951_Dianna-Wil_1920x1080.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/GMT20200611-124951_Dianna-Wil_1920x1080.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/52D80A43.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/GMT20200611-124951_Dianna-Wil_1920x1080.vtt"}]},{"name":"FOLLOW-UP OF ATYPIAL GLANDULAR CELLS: RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER \u003Csmall\u003E(ID 162)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":162,"presentation":"FOLLOW-UP OF ATYPIAL GLANDULAR CELLS: RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER \u003Csmall\u003E(ID 162)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Jiangrong Wang (Sweden)","photo":""},"playlist":[{"name":"FOLLOW-UP OF ATYPIAL GLANDULAR CELLS: RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVIC","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Jiangrong Wang - IPVC20 - 162 - FOLLOW-UP OF ATYPIAL GLANDULAR CELLS RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Jiangrong Wang - IPVC20 - 162 - FOLLOW-UP OF ATYPIAL GLANDULAR CELLS RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/1BCEBB2A.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Jiangrong Wang - IPVC20 - 162 - FOLLOW-UP OF ATYPIAL GLANDULAR CELLS RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER.vtt"}]},{"name":"ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN \u003Csmall\u003E(ID 901)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":901,"presentation":"ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN \u003Csmall\u003E(ID 901)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Bengt Andrae (Sweden)","photo":""},"playlist":[{"name":"ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Bengt Andrae -IPVC20 - 901 -ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Bengt Andrae -IPVC20 - 901 -ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/B0AC2C2B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Bengt Andrae -IPVC20 - 901 -ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN.vtt"}]},{"name":"CERVICAL PRECANCER (CIN2\/3\/AIS) LATER DIAGNOSED WITH CERVICAL CANCER BY SOCIODEMOGRAPHIC FACTORS, SEVERITY OF DIAGNOSIS, AND HPV-TYPE, ALAMEDA COUNTY, CALIFORNIA, UNITED STATES (U.S.), 2008-2018 \u003Csmall\u003E(ID 1055)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1055,"presentation":"CERVICAL PRECANCER (CIN2\/3\/AIS) LATER DIAGNOSED WITH CERVICAL CANCER BY SOCIODEMOGRAPHIC FACTORS, SEVERITY OF DIAGNOSIS, AND HPV-TYPE, ALAMEDA COUNTY, CALIFORNIA, UNITED STATES (U.S.), 2008-2018 \u003Csmall\u003E(ID 1055)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Erin Whitney (United States of America)","photo":""},"playlist":[{"name":"Martina Rojnic Kuzman - EPA2020 - 4,963 - Can Psychosocial Treatment Reduce Antipsychotic-Induced Me","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Erin Whitney - Record your lecture - IPVC20.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Erin Whitney - Record your lecture - IPVC20.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/7AA7C450.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Erin Whitney - Record your lecture - IPVC20.vtt"}]},{"name":"PREDICTING COHORT-SPECIFIC CERVICAL CANCER INCIDENCE FROM POPULATION-BASED HPV PREVALENCE SURVEYS: A WORLDWIDE STUDY \u003Csmall\u003E(ID 531)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":531,"presentation":"PREDICTING COHORT-SPECIFIC CERVICAL CANCER INCIDENCE FROM POPULATION-BASED HPV PREVALENCE SURVEYS: A WORLDWIDE STUDY \u003Csmall\u003E(ID 531)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Iacopo Baussano (France)","photo":""},"playlist":[{"name":"PREDICTING COHORT-SPECIFIC CERVICAL CANCER INCIDENCE FROM POPULATION-BASED HPV PREVALENCE SURVEYS: A","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Iacopo Baussano - IPVC20 - PRESENTATION 531.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Iacopo Baussano - IPVC20 - PRESENTATION 531.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/7BA30EE1.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Iacopo Baussano - IPVC20 - PRESENTATION 531.vtt"}]}]
{"type":2,"code":"7E32UU022"}
[session]
[presentation]
[presenter]